Advertisement

 

 

Patient-Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis.

Patient-Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis.
Author Information (click to view)

Ferrada MA, Grayson PC, Banerjee S, Sikora K, Colbert R, Sinaii N, Katz JD,


Ferrada MA, Grayson PC, Banerjee S, Sikora K, Colbert R, Sinaii N, Katz JD, (click to view)

Ferrada MA, Grayson PC, Banerjee S, Sikora K, Colbert R, Sinaii N, Katz JD,

Advertisement

Arthritis care & research 2017 12 15() doi 10.1002/acr.23492
Abstract
OBJECTIVE
To assess patient-reported symptoms and burden of disease in relapsing polychondritis (RP).

METHODS
Patients with RP completed a disease-specific online survey to identify symptoms attributed to illness. Patients were divided into subgroups based upon presence or absence of ear/nose, airway, or joint involvement. Pathway to diagnosis, treatment, and disease-related complications were assessed within each subgroup.

RESULTS
Data from 304 respondents were included in this analysis. Prior to diagnosis, most patients with RP went to the emergency room (54%), saw >3 physicians (54%), and had symptoms for >5 years (64%). A concomitant diagnosis of fibromyalgia and absence of ear/nose or joint involvement was associated with diagnostic delay >1 year. Common diagnoses prior to RP diagnosis included asthma in patients with airway involvement (35% vs 22%, p=0.03) and ear infection in patients with ear/nose involvement (51% vs 6%, p<0.01). Patients with joint involvement were more likely to receive a glucocorticoid-sparing agent (85% vs 13%, p<0.01). Most patients reported a major complication including disability (25%), tracheomalacia (16%) or hearing loss (34%). Patients with airway involvement reported more tracheomalacia (20% vs 4%, p<0.01). Disability (24% vs 7%, p<0.01) and hearing loss (39% vs 11%, p<0.01) were prevalent in the joint involvement subgroup. CONCLUSION
Patient-reported data in RP highlight a significant burden of disease. Patterns of organ involvement may lead to diagnostic delay and influence treatment decisions, ultimately impacting the development of disease-related complications. Timely diagnosis, standardization of treatment approaches, and prevention of disease-related complications are major unmet needs in RP. This article is protected by copyright. All rights reserved.

Submit a Comment

Your email address will not be published. Required fields are marked *

fifteen − 6 =

[ HIDE/SHOW ]